Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3643 | 1938 | 49.5 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
29 | 3 | HIV//VIROLOGY//HIV 1 | 108954 |
10 | 2 | AIDS RESEARCH AND HUMAN RETROVIRUSES//VIROLOGY//HIV 1 | 39664 |
3643 | 1 | HIV LATENCY//HIV RESERVOIR//HIV CURE | 1938 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HIV LATENCY | authKW | 660485 | 3% | 79% | 53 |
2 | HIV RESERVOIR | authKW | 434741 | 3% | 56% | 49 |
3 | HIV CURE | authKW | 289343 | 2% | 61% | 30 |
4 | HIV 1 LATENCY | authKW | 266105 | 1% | 68% | 25 |
5 | VIRAL RESERVOIR | authKW | 219385 | 2% | 45% | 31 |
6 | HIV DNA | authKW | 216663 | 1% | 49% | 28 |
7 | TREATMENT INTERRUPTION | authKW | 198446 | 2% | 30% | 42 |
8 | RESTING CD4 T CELLS | authKW | 190176 | 1% | 93% | 13 |
9 | HIV PERSISTENCE | authKW | 171541 | 1% | 78% | 14 |
10 | LATENT RESERVOIR | authKW | 161115 | 1% | 68% | 15 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Virology | 68785 | 45% | 1% | 875 |
2 | Infectious Diseases | 36296 | 41% | 0% | 789 |
3 | Immunology | 11574 | 37% | 0% | 726 |
4 | Microbiology | 2958 | 17% | 0% | 336 |
5 | Medicine, Research & Experimental | 485 | 7% | 0% | 136 |
6 | Parasitiology | 377 | 3% | 0% | 58 |
7 | Multidisciplinary Sciences | 305 | 2% | 0% | 46 |
8 | Pharmacology & Pharmacy | 168 | 8% | 0% | 157 |
9 | Cell Biology | 165 | 7% | 0% | 132 |
10 | Mathematical & Computational Biology | 80 | 1% | 0% | 29 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SERV MOL VIROL | 84018 | 0% | 67% | 8 |
2 | HOSP UNIV CHU LIEGE | 50412 | 0% | 80% | 4 |
3 | HIV TRANSLAT UNIT | 50404 | 0% | 40% | 8 |
4 | MICHAEL HOOKER 3302 | 47263 | 0% | 100% | 3 |
5 | IUT LOUIS PASTEUR ILTIGHEIM | 42009 | 0% | 67% | 4 |
6 | IMMUNOREGULAT | 39466 | 3% | 4% | 61 |
7 | GLADSTONE VIROL IMMUNOL | 37802 | 1% | 8% | 29 |
8 | CLIN EAR NOSE THROAT SURG | 35446 | 0% | 75% | 3 |
9 | AIDS | 31845 | 5% | 2% | 100 |
10 | BASIC PL IMMUNOL SECT | 31509 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CURRENT OPINION IN HIV AND AIDS | 70516 | 3% | 7% | 61 |
2 | AIDS | 54719 | 9% | 2% | 173 |
3 | RETROVIROLOGY | 43509 | 3% | 5% | 58 |
4 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 16488 | 4% | 1% | 75 |
5 | JOURNAL OF VIROLOGY | 13297 | 9% | 0% | 184 |
6 | CURRENT HIV/AIDS REPORTS | 11402 | 1% | 6% | 13 |
7 | CURRENT HIV RESEARCH | 11020 | 1% | 3% | 24 |
8 | JOURNAL OF INFECTIOUS DISEASES | 10122 | 6% | 1% | 107 |
9 | ANTIVIRAL THERAPY | 9672 | 2% | 2% | 34 |
10 | JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 7837 | 2% | 1% | 46 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HIV LATENCY | 660485 | 3% | 79% | 53 | Search HIV+LATENCY | Search HIV+LATENCY |
2 | HIV RESERVOIR | 434741 | 3% | 56% | 49 | Search HIV+RESERVOIR | Search HIV+RESERVOIR |
3 | HIV CURE | 289343 | 2% | 61% | 30 | Search HIV+CURE | Search HIV+CURE |
4 | HIV 1 LATENCY | 266105 | 1% | 68% | 25 | Search HIV+1+LATENCY | Search HIV+1+LATENCY |
5 | VIRAL RESERVOIR | 219385 | 2% | 45% | 31 | Search VIRAL+RESERVOIR | Search VIRAL+RESERVOIR |
6 | HIV DNA | 216663 | 1% | 49% | 28 | Search HIV+DNA | Search HIV+DNA |
7 | TREATMENT INTERRUPTION | 198446 | 2% | 30% | 42 | Search TREATMENT+INTERRUPTION | Search TREATMENT+INTERRUPTION |
8 | RESTING CD4 T CELLS | 190176 | 1% | 93% | 13 | Search RESTING+CD4+T+CELLS | Search RESTING+CD4+T+CELLS |
9 | HIV PERSISTENCE | 171541 | 1% | 78% | 14 | Search HIV+PERSISTENCE | Search HIV+PERSISTENCE |
10 | LATENT RESERVOIR | 161115 | 1% | 68% | 15 | Search LATENT+RESERVOIR | Search LATENT+RESERVOIR |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | AVETTAND-FENOEL, V , HOCQUELOUX, L , GHOSN, J , CHERET, A , FRANGE, P , MELARD, A , VIARD, JP , ROUZIOUX, C , (2016) TOTAL HIV-1 DNA, A MARKER OF VIRAL RESERVOIR DYNAMICS WITH CLINICAL IMPLICATIONS.CLINICAL MICROBIOLOGY REVIEWS. VOL. 29. ISSUE 4. P. 859 -880 | 169 | 67% | 1 |
2 | VAN LINT, C , BOUCHAT, S , MARCELLO, A , (2013) HIV-1 TRANSCRIPTION AND LATENCY: AN UPDATE.RETROVIROLOGY. VOL. 10. ISSUE . P. - | 177 | 46% | 78 |
3 | BRUNER, KM , HOSMANE, NN , SILICIANO, RF , (2015) TOWARDS AN HIV-1 CURE: MEASURING THE LATENT RESERVOIR.TRENDS IN MICROBIOLOGY. VOL. 23. ISSUE 4. P. 192 -203 | 80 | 78% | 48 |
4 | BATTISTINI, A , SGARBANTI, M , (2014) HIV-1 LATENCY: AN UPDATE OF MOLECULAR MECHANISMS AND THERAPEUTIC STRATEGIES.VIRUSES-BASEL. VOL. 6. ISSUE 4. P. 1715 -1758 | 152 | 56% | 16 |
5 | SPIVAK, AM , PLANELLES, V , (2016) HIV-1 ERACICATION: EARLY TRIALS (AND TRIBULATIONS).TRENDS IN MOLECULAR MEDICINE. VOL. 22. ISSUE 1. P. 10 -27 | 74 | 79% | 9 |
6 | LAIRD, GM , BULLEN, CK , ROSENBLOOM, DIS , MARTIN, AR , HILL, AL , DURAND, CM , SILICIANO, JD , SILICIANO, RF , (2015) EX VIVO ANALYSIS IDENTIFIES EFFECTIVE HIV-1 LATENCY-REVERSING DRUG COMBINATIONS.JOURNAL OF CLINICAL INVESTIGATION. VOL. 125. ISSUE 5. P. 1901 -1912 | 51 | 93% | 69 |
7 | ERIKSSON, S , GRAF, EH , DAHL, V , STRAIN, MC , YUKL, SA , LYSENKO, ES , BOSCH, RJ , LAI, J , CHIOMA, S , EMAD, F , ET AL (2013) COMPARATIVE ANALYSIS OF MEASURES OF VIRAL RESERVOIRS IN HIV-1 ERADICATION STUDIES.PLOS PATHOGENS. VOL. 9. ISSUE 2. P. - | 69 | 86% | 110 |
8 | DE CRIGNIS, E , MAHMOUDI, T , (2014) HIV ERADICATION: COMBINATORIAL APPROACHES TO ACTIVATE LATENT VIRUSES.VIRUSES-BASEL. VOL. 6. ISSUE 11. P. 4581 -4608 | 121 | 72% | 3 |
9 | MELKOVA, Z , SHANKARAN, P , MADLENAKOVA, M , BODOR, J , (2017) CURRENT VIEWS ON HIV-1 LATENCY, PERSISTENCE, AND CURE.FOLIA MICROBIOLOGICA. VOL. 62. ISSUE 1. P. 73 -87 | 91 | 54% | 1 |
10 | DONAHUE, DA , WAINBERG, MA , (2013) CELLULAR AND MOLECULAR MECHANISMS INVOLVED IN THE ESTABLISHMENT OF HIV-1 LATENCY.RETROVIROLOGY. VOL. 10. ISSUE . P. - | 93 | 73% | 40 |
Classes with closest relation at Level 1 |